FDA PMA FDA Class 3 Approved 🇺🇸 United States

Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter

PMA: P010068 · Supplement: S031 · Decision Jun 6, 2013
Classifications
1
FEI Numbers
46
Registration Numbers
46

Basic Information

Device Name
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter
Trade Name
UNI-DIRECTIONAL CELSIUS FLTR CATHETERS (D-1355-XX S)
PMA Number
P010068
Supplement Number
S031
Device Class
FDA Class 3
Product Code
OAD
Generic Name
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
June 6, 2013
Date Received
November 7, 2012
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR MODIFIED CATHETER DESIGNS TO THE 7FR CELSIUS AND 7FR EZ STEER DS CATHETERS TO CREATE THE 7.5FR 8 MM CELSIUS FLTR CATHETERS. THE CHANGES BEING APPROVED ARE THE INCREASED DISTAL PROFILE, LARGER CURVE PROFILE, INCREASED RANGE OF DEFLECTION, AND INCREASED DEFLECTABLE TIP DIAMETER. THE DEVICES, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAMES BI-DIRECTIONAL CELSIUS FLTR CATHETERS (D-1359-XX-S) AND UNI-DIRECTIONAL CELSIUS FLTR CATHETERS (D-1355-XX-S) AND ARE INDICATED FOR CATHETER-BASED CARDIAC ELECTROPHYSIOLOGICAL MAPPING (STIMULATION AND RECORDING), AND WHEN USED WITH THE STOCKERT 70 (WITH SOFTWARE VERSION 001/033 OR HIGHER) FOR THE TREATMENT OF TYPE I ATRIAL FLUTTER IN PATIENTS AGE 18 YEARS OF AGE OR OLDER.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OAD Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter